Literature DB >> 15358094

Metabolism of A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 by CYP24A1.

Tatsuya Kusudo1, Toshiyuki Sakaki, Daisuke Abe, Toshie Fujishima, Atsushi Kittaka, Hiroaki Takayama, Susumi Hatakeyama, Miho Ohta, Kuniyo Inouye.   

Abstract

The metabolism of 1alpha,25(OH)(2)D(3) (1alpha,3beta) and its A-ring diastereomers, 1beta,25(OH)(2)D(3) (1beta,3beta), 1alpha,25(OH)(2)-3-epi-D(3) (1alpha,3alpha), and 1beta,25(OH)(2)-3-epi-D(3) (1beta,3alpha), was examined to compare the substrate specificity and reaction specificity of CYP24A1 between humans and rats. The ratio between C-23 and C-24 oxidation pathways in human CYP24A1-dependent metabolism of (1alpha,3alpha) and (1beta,3alpha) was 1:1, although the ratio for (1alpha,3beta) and (1beta,3beta) was 1:4. These results indicate that the orientation of the hydroxyl group at the C-3 position determines the ratio between C-23 and C-24 oxidation pathways. A remarkable increase of metabolites in the C-23 oxidation pathway was also observed in rat CYP24A1-dependent metabolism. The binding affinity of human CYP24A1 for A-ring diastereomers was (1alpha,3beta)>(1alpha,3alpha)>(1beta,3beta)>(1beta,3alpha), indicating that both hydroxyl groups at C-1 and C-3 positions significantly affect substrate-binding. The information obtained in this study is quite useful for understanding substrate recognition of CYP24A1 and designing new vitamin D analogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358094     DOI: 10.1016/j.bbrc.2004.07.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.

Authors:  Elaine W Tieu; Wei Li; Jianjun Chen; Tae-Kang Kim; Dejian Ma; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-02-26       Impact factor: 4.292

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.

Authors:  Galina Nesterova; May Christine Malicdan; Kaori Yasuda; Toshiyuki Sakaki; Thierry Vilboux; Carla Ciccone; Ronald Horst; Yan Huang; Gretchen Golas; Wendy Introne; Marjan Huizing; David Adams; Cornelius F Boerkoel; Michael T Collins; William A Gahl
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

4.  A new insight into the role of rat cytochrome P450 24A1 in metabolism of selective analogs of 1α,25-dihydroxyvitamin D₃.

Authors:  Steve Y Rhieu; Andrew J Annalora; Rose M Gathungu; Paul Vouros; Milan R Uskokovic; Inge Schuster; G Tayhas R Palmore; G Satyanarayana Reddy
Journal:  Arch Biochem Biophys       Date:  2011-02-19       Impact factor: 4.013

5.  Characterization of a Cleavable Fusion of Human CYP24A1 with Adrenodoxin Reveals the Variable Role of Hydrophobics in Redox Partner Binding.

Authors:  Natalie Jay; Sean R Duffy; D Fernando Estrada
Journal:  Biochemistry       Date:  2022-01-03       Impact factor: 3.162

6.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine.

Authors:  William A Gahl; John J Mulvihill; Camilo Toro; Thomas C Markello; Anastasia L Wise; Rachel B Ramoni; David R Adams; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2016-01-22       Impact factor: 4.797

Review 7.  The serum vitamin D metabolome: What we know and what is still to discover.

Authors:  Robert C Tuckey; Chloe Y S Cheng; Andrzej T Slominski
Journal:  J Steroid Biochem Mol Biol       Date:  2018-09-08       Impact factor: 4.292

8.  Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by Cyp24a1 and Cyp3a using Cyp24a1 knockout rats generated by CRISPR/Cas9 system.

Authors:  Kaori Yasuda; Miyu Nishikawa; Kairi Okamoto; Kyohei Horibe; Hiroki Mano; Mana Yamaguchi; Risa Okon; Kimie Nakagawa; Naoko Tsugawa; Toshio Okano; Fumihiro Kawagoe; Atsushi Kittaka; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  J Biol Chem       Date:  2021-04-15       Impact factor: 5.157

9.  Human hepatic metabolism of the anti-osteoporosis drug eldecalcitol involves sterol C4-methyl oxidase.

Authors:  Kaori Yasuda; Yuasa Iwanaga; Kazuaki Ogawa; Hiroki Mano; Sera Ueno; Shutaro Kimoto; Miho Ohta; Masaki Kamakura; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

10.  Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.

Authors:  Aoife Corcoran; Sharmin Nadkarni; Kaori Yasuda; Toshiyuki Sakaki; Geoffrey Brown; Andrzej Kutner; Ewa Marcinkowska
Journal:  Int J Mol Sci       Date:  2016-02-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.